MaxQ Medical Raises $31.5 Million for Prostate Care Platform
Aug 20, 2026
Funding
Thyme Care Raises Over $125 Million and Forms Thyme Companies
Sep 2, 2026
Thyme Care raised over $125 million in Series E funding led by Morgan Health and formed Thyme Companies, a parent entity for new oncology businesses.
Thyme Care raised over $125 million in Series E funding led by Morgan Health, with participation from Humana, CVS Health Ventures, and other investors, the company announced in a press release.
Other participants included AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. Thyme Care said its services are available to more than 10.5 million people across all 50 states and that it manages more than $7 billion in oncology spending.
Alongside the funding, Thyme Care formed Thyme Companies as a parent entity for new independent oncology businesses. Areas in active development include adoption of lower cost biosimilars and clinical trial accrual, with the first business expected to launch later this year.
Co founder Robin Shah will serve as executive chairman of Thyme Companies. Thyme Care will continue under CEO Brad Diephuis, with Bobby Green serving as president and chief medical officer.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Sep 12 Nscale Adds Fidji Simo to a Board Built for Scale Sep 11 Evergreen Digital Media Invests in Adwave and Licenses AI Ad Platform Sep 11 Intermezzo Raises $10 Million for Global Payroll Platform Sep 11 UrgentIQ Raises $15 Million for AI Clinical Workflows Sep 11 FAZE Security Emerges From Stealth With $6 Million Seed RoundMore from Life Sciences
Sep 12 Aignostics Opens Early Access to PathoSearch Sep 11 Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis Sep 11 UrgentIQ Raises $15 Million for AI Clinical Workflows Sep 11 Penguin Ai Launches Revenue Cycle AI Platform Sep 11 MegazoneCloud Builds Quality Assurance AI Agent for Hanmi PharmaceuticalFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Hopscotch Primary Care Raises $53 Million for Rural Health Care Expansion
Aug 18, 2026
Healthcare
Arintra Raises $25 Million for Healthcare Revenue Assurance AI
Aug 26, 2026
Healthcare
Ours Privacy Raises $15M for Healthcare Marketing Data Platform
Aug 19, 2026
Funding
UrgentIQ Raises $15 Million for AI Clinical Workflows
Sep 11, 2026
Funding
Curavit Acquires Lindus Health CRO Assets
Aug 19, 2026
Acquisitions
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.